Globus Medical, Inc. Class A Common Stock (NY:GMED)

76.57 +0.97 (+1.28%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today ↗

May 20, 2024

Via Benzinga

Key Takeaways From Globus Medical Analyst Ratings ↗

May 09, 2024

Via Benzinga

Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results ↗

May 08, 2024

Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 08, 2024

Via Benzinga

Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday ↗

May 08, 2024

Via Benzinga

Looking for growth without the hefty price tag? Consider NYSE:GMED. ↗

April 11, 2024

Via Chartmill

The Latest Analyst Ratings For Globus Medical ↗

March 18, 2024

Via Benzinga

Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 08, 2024

Via Benzinga

Globus Medical (GMED) Q1 2024 Earnings Call Transcript ↗

May 08, 2024

GMED earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

NYSE:GMED is not too expensive for the growth it is showing. ↗

February 28, 2024

Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.

Via Chartmill

Key Takeaways From Globus Medical Analyst Ratings ↗

February 21, 2024

Via Benzinga

Globus Medical: Q4 Earnings Insights ↗

February 20, 2024

Via Benzinga

Why NYSE:GMED Is a Standout High-Growth Stock in a Consolidation Phase. ↗

January 30, 2024

GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move.

Via Chartmill

GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Globus Medical Reports First Quarter 2024 Results

May 07, 2024

From Globus Medical

Via GlobeNewswire

Investors should take note of NYSE:GMED, a growth stock that remains attractively priced. ↗

May 02, 2024

For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering.

Via Chartmill

Globus Medical Schedules First Quarter Earnings Release and Conference Call

April 16, 2024

From Globus Medical

Via GlobeNewswire

From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires ↗

March 24, 2024

With automated machines set to integrate into everyday functionalities, these are the robotics stocks that could make you rich.

Via InvestorPlace

Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation. ↗

March 21, 2024

For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering.

Via Chartmill

7 Robotic Surgery Stocks to Buy for the Future of Healthcare ↗

March 13, 2024

Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.

Via InvestorPlace

Exploring GLOBUS MEDICAL INC - A's Technical Signals and Breakout Potential. ↗

March 11, 2024

With a solid technical rating of 7 out of 10, GLOBUS MEDICAL INC - A (NYSE:GMED) is showing strong indications of a possible breakout.

Via Chartmill

Globus Medical (GMED) Q4 2023 Earnings Call Transcript ↗

February 20, 2024

GMED earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Globus Medical Reports Fourth Quarter and Full Year 2023 Results

February 20, 2024

From Globus Medical

Via GlobeNewswire

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

February 13, 2024

From Globus Medical

Via GlobeNewswire

Investors seeking growth at a reasonable cost should explore NYSE:GMED. ↗

February 07, 2024

While growth is established for GLOBUS MEDICAL INC - A (NYSE:GMED), the stock's valuation remains reasonable.

Via Chartmill

Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

February 05, 2024

Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth

From Globus Medical

Via GlobeNewswire

Do Investors Have Too Much Money Out of the Market? ↗

January 28, 2024

We've also got a look at two stocks worth watching: Globus Medical and RPM International.

Via The Motley Fool

NYSE:GMED stands out as a growth opportunity that won't break the bank. ↗

January 17, 2024

Despite its growth, GLOBUS MEDICAL INC - A (NYSE:GMED) remains within the realm of affordability.

Via Chartmill

7 Healthcare Stocks Taking Medicine to the Next Level ↗

January 14, 2024

With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.